Cargando…

Editorial: Update on the Biology, Management, and Treatment of Small Cell Lung Cancer

Detalles Bibliográficos
Autores principales:	Puri, Sonam, Lok, Benjamin H., Leighl, Natasha, Gray, Jhanelle E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7705219/ https://www.ncbi.nlm.nih.gov/pubmed/33282719 http://dx.doi.org/10.3389/fonc.2020.01783

Ejemplares similares

Update on the Treatment of Metastatic Squamous Non-Small Cell Lung Cancer in New Era of Personalized Medicine
por: Soldera, Sara Victoria, et al.
Publicado: (2017)

Update on the Biology, Management, and Treatment of Small Cell Lung Cancer (SCLC)
por: Saltos, Andreas, et al.
Publicado: (2020)

Editorial: Update on the Treatment of Metastatic Non-small Cell Lung Cancer (NSCLC) in New Era of Personalised Medicine
por: Melosky, Barbara
Publicado: (2017)

Third-Generation Tyrosine Kinase Inhibitors Targeting Epidermal Growth Factor Receptor Mutations in Non-Small Cell Lung Cancer
por: Barnes, Tristan A., et al.
Publicado: (2017)

Economic Impact of Tissue Testing and Treatments of Metastatic NSCLC in the Era of Personalized Medicine
por: Graham, Donna M., et al.
Publicado: (2014)

Biomarkers That Currently Affect Clinical Practice in Lung Cancer: EGFR, ALK, MET, ROS-1, and KRAS
por: Korpanty, Grzegorz J., et al.
Publicado: (2014)

Editorial: Treatment for Non-Small Cell Lung Cancer in Distinct Patient Populations
por: Uchino, Junji, et al.
Publicado: (2022)

Editorial: Quality of Life and Side Effects Management in Lung Cancer Treatment
por: Molassiotis, Alex, et al.
Publicado: (2021)

Combination checkpoint inhibitors for treatment of non-small-cell lung cancer: an update on dual anti-CTLA-4 and anti-PD-1/PD-L1 therapies
por: Puri, Sonam, et al.
Publicado: (2020)

Editorial: Imaging in non-small cell lung cancer
por: Liu, Yiyan
Publicado: (2023)

Editorial: Controversies in the Local Management of Lung Cancer
por: Varlotto, John M., et al.
Publicado: (2018)

Editorial: Prognostic factors in non-small cell lung cancer
por: Rahouma, Mohamed, et al.
Publicado: (2023)

Promising Targets and Current Clinical Trials in Metastatic Non-Squamous NSCLC
por: Zer, Alona, et al.
Publicado: (2014)

Editorial: Local ablative therapies for the management of lung cancer
por: Wei, Zhigang, et al.
Publicado: (2023)

Editorial: Chordoma: advances in biology and clinical management
por: Gardner, Paul, et al.
Publicado: (2023)

Editorial: Factors that impact the survival of non-small cell lung cancer
por: Hegi-Johnson, Fiona, et al.
Publicado: (2023)

Biomarkers of therapeutic response with immune checkpoint inhibitors
por: Bindal, Poorva, et al.
Publicado: (2021)

Editorial: Update of Current Evidences in Breast Cancer Surgery
por: Franceschini, Gianluca, et al.
Publicado: (2022)

Editorial: Application of nanotechnology in diagnosis and/or therapy of non-small cell lung cancer
por: Shen, Qinglin, et al.
Publicado: (2023)

Multiple primary lung cancer: Updates of clinical management and genomic features
por: Tian, He, et al.
Publicado: (2023)

Therapeutic strategies for BRAF mutation in non-small cell lung cancer: a review
por: Puri, Megha, et al.
Publicado: (2023)

Editorial: Biology and treatment of high-risk CLL
por: Tausch, Eugen, et al.
Publicado: (2023)

Editorial: The effect of anti-cancer drug therapies in the treatment of lung cancer
por: Pisapia, Pasquale, et al.
Publicado: (2022)

Sex difference in response to non-small cell lung cancer immunotherapy: an updated meta-analysis
por: Liang, Jiali, et al.
Publicado: (2022)

Emerging therapies for non-small cell lung cancer
por: Zhang, Chao, et al.
Publicado: (2019)

Update on Programmed Death-1 and Programmed Death-Ligand 1 Inhibition in the Treatment of Advanced or Metastatic Non-Small Cell Lung Cancer
por: Iafolla, Marco A. J., et al.
Publicado: (2017)

Afatinib for the Treatment of Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: An Updated Database of 1023 Cases Brief Report
por: Yang, James Chih-Hsin, et al.
Publicado: (2022)

Editorial: Immune-Related Adverse Events for Patients With Lung Cancer
por: Yang, Ruoning, et al.
Publicado: (2022)

The Management of Brain Metastases in Non-Small Cell Lung Cancer
por: Owen, Scott, et al.
Publicado: (2014)

Current Management and Progress in Radiotherapy for Small Cell Lung Cancer
por: Tjong, Michael C., et al.
Publicado: (2020)

Editorial: Impact of immunotherapy in lung cancer
por: Ferreira, Marion, et al.
Publicado: (2022)

Editorial: NK/T-Cell Lymphoma: Biology, Prognostics, Prediction, and Treatment
por: El Cheikh, Jean, et al.
Publicado: (2022)

Editorial: Molecular biology of biomarkers in diagnosis and treatment of glioblastoma multiforme
por: Zhao, Jianyi, et al.
Publicado: (2023)

Editorial: Single cell meets metabolism and cancer biology
por: Wang, Jieqiong, et al.
Publicado: (2023)

Editorial: Vascular co-option and beyond for cancer biology
por: Pezzella, Francesco, et al.
Publicado: (2023)

Clinical outcomes of ramucirumab plus docetaxel in the treatment of patients with non-small cell lung cancer after immunotherapy: a systematic literature review
por: Garon, Edward B., et al.
Publicado: (2023)

Editorial: News and update in transoral robotic surgery in oropharyngeal, hypopharyngeal, and laryngeal cancers
por: Mat Lazim, Norhafiza, et al.
Publicado: (2023)

Review of the use of pretest probability for molecular testing in non-small cell lung cancer and overview of new mutations that may affect clinical practice
por: Martin, Petra, et al.
Publicado: (2017)

Brain Metastases in Oncogene-Addicted Non-Small Cell Lung Cancer Patients: Incidence and Treatment
por: Remon, J., et al.
Publicado: (2018)

Clinical Applications of Circulating Tumour Cells and Circulating Tumour DNA in Non-Small Cell Lung Cancer—An Update
por: Kapeleris, Joanna, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_66f2qkhvpta3gcf76dp125302r